Safety and efficacy of continuous insulin infusion in noncritical care settings.
BACKGROUND
Continuous insulin infusion (CII) to manage hyperglycemia is the accepted standard of care in the intensive care unit (ICU); however, the safety and efficacy of CII in the non-ICU setting has not been determined.


METHODS
This is a retrospective analysis of 200 consecutive patients receiving CII while admitted to general medical-surgical units at Emory University Hospital. We evaluated clinical outcomes and rates of hyperglycemia (blood glucose [BG] >200 mg/dL) and hypoglycemia (BG <60 mg/dL) events during CII.


RESULTS
A total of 200 patients (age 52 +/- 16 years; male/female [M/F] 108/92) were admitted to general medicine (45%) or surgery (55%) services, 88.5% with history of diabetes and 41% treated with corticosteroids. The mean BG prior to and during the CII was 323 mg/dL and 170 mg/dL, respectively. Blood glucose of <or=150 mg/dL was the targeted goal in 85% of patients and 67% achieved a BG <or=150 mg/dL by hospital day 2. Hypoglycemia (BG <60 mg/dL) occurred at least once in 22% of patients, and severe hypoglycemia (BG <40 mg/dL) occurred in 5% of patients. Multivariate regression analyses showed that nutrition status during CII was associated with increased frequency of hyperglycemia and hypoglycemia. Compared to patients kept nil per os (NPO), oral intake during CII increased rates of hyperglycemic (P = 0.012) and hypoglycemic events (P = 0.035).


CONCLUSIONS
CII resulted in rapid and sustained glycemic control and a rate of hypoglycemic events similar to that reported in recent ICU trials. The rates of hypoglycemic and hyperglycemic events are significantly higher in patients allowed to eat during CII.
Smiley
Dawn
D
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30303, USA. dsmiley@emory.edu
Rhee
Mary
M
Peng
Limin
L
Roediger
Laurian
L
Mulligan
Patrick
P
Satterwhite
Lewis
L
Bowen
Patrick
P
Umpierrez
Guillermo E
GE
D000368:Aged; D001786:Blood Glucose / Q000187:drug effects; D005260:Female; D005845:Georgia; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy*; D055104:Infusions, Subcutaneous / Q000379:methods*; D007297:Inpatients; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D017751:Safety Management; D016896:Treatment Outcome
D001786:Blood Glucose; D007328:Insulin
Chest. 2006 Mar;129(3):644-50
16537863
J Thorac Cardiovasc Surg. 2003 May;125(5):1007-21
12771873
Diabetes Care. 2007 Sep;30(9):2181-6
17513708
J Clin Endocrinol Metab. 2009 Feb;94(2):564-9
19017758
N Engl J Med. 2001 Nov 8;345(19):1359-67
11794168
Diabetes Care. 2004 Feb;27(2):553-91
14747243
Jt Comm J Qual Patient Saf. 2005 Mar;31(3):141-7
15828597
Endocr Pract. 2009 May-Jun;15(4):353-69
19454396
J Am Coll Cardiol. 1995 Jul;26(1):57-65
7797776
J Clin Endocrinol Metab. 2002 Mar;87(3):978-82
11889147
Crit Care Med. 2006 Nov;34(11):2714-8
16943734
Diabetes Care. 2004 Feb;27(2):461-7
14747229
JAMA. 2003 Oct 15;290(15):2041-7
14559958
N Engl J Med. 2008 Jan 10;358(2):125-39
18184958
Diab Vasc Dis Res. 2008 Nov;5(4):269-75
18958836
Crit Care Med. 2007 Oct;35(10):2262-7
17717490
CMAJ. 2009 Apr 14;180(8):821-7
19318387
Arch Intern Med. 1997 Mar 10;157(5):545-52
9066459
Crit Care. 2008;12(5):R120
18799004
N Engl J Med. 2006 Feb 2;354(5):449-61
16452557
Crit Care Med. 2003 Feb;31(2):359-66
12576937
Circulation. 2008 Mar 25;117(12):1610-9
18299505
N Engl J Med. 2009 Mar 26;360(13):1283-97
19318384
JPEN J Parenter Enteral Nutr. 1998 Mar-Apr;22(2):77-81
9527963